Boston University (BU) and the National Institutes of Health (NIH) are preparing a mandatory revised risk assessment for BU’s National Emerging Infectious Disease Laboratories (NEIDL), which has received substantial federal funding through NIH. I described the specifics of this risk assessment in an earlier post. The draft of that risk assessment is currently ready for public review. Though we reported in our last post that the public hearing for NIH’s draft risk assessment would be held February 16, that hearing was delayed by NIH. NIH recently announced that the hearing has been rescheduled for April 19 and that they are accepting public comments on the draft risk assessment. Your input in this public process is crucial – here is how you can get involved: Review the Draft Risk Assessment: The first read more…
- Karen Giarrusso on Egregiously Incomplete: DOE Should Reject Northern Pass’s New Presidential Permit Application
- Christophe Courchesne on Northern Pass Update: New Opportunities to Make Your Voice Heard
- Lynne R. Sellers on Vermont Yankee Closing: Advocacy and Activism Kept Pressure on Aging Plant
- Scott Hening on Northern Pass Update: New Opportunities to Make Your Voice Heard
